BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31920463)

  • 21. Aurora A Kinase Plays a Key Role in Mitosis Skip during Senescence Induced by Ionizing Radiation.
    Zhang XR; Zhang TS; Zhang YN; Hua JR; Wang JF; He JP
    Biomed Environ Sci; 2023 Oct; 36(10):903-916. PubMed ID: 37932059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer.
    Chen A; Wen S; Liu F; Zhang Z; Liu M; Wu Y; He B; Yan M; Kang T; Lam EW; Wang Z; Liu Q
    Cancer Commun (Lond); 2021 Feb; 41(2):121-139. PubMed ID: 33471959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.
    Felgenhauer J; Tomino L; Selich-Anderson J; Bopp E; Shah N
    Neoplasia; 2018 Oct; 20(10):965-974. PubMed ID: 30153557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
    Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
    Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
    Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
    Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with
    Kumar P; Koach J; Nekritz E; Mukherjee S; Braun BS; DuBois SG; Nasholm N; Haas-Kogan D; Matthay KK; Weiss WA; Gustafson C; Seo Y
    EJNMMI Res; 2024 Jun; 14(1):54. PubMed ID: 38869684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with
    Kumar P; Koach J; Nekritz E; Mukherjee S; Braun BS; DuBois SG; Nasholm N; Haas-Kogan D; Matthay KK; Weiss WA; Gustafson C; Seo Y
    Res Sq; 2024 Jan; ():. PubMed ID: 38313265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells.
    Levesley J; Steele L; Brüning-Richardson A; Davison A; Zhou J; Ding C; Lawler S; Short SC
    Neuro Oncol; 2018 Jan; 20(2):203-214. PubMed ID: 29016820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
    Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
    Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
    Muscal JA; Scorsone KA; Zhang L; Ecsedy JA; Berg SL
    Invest New Drugs; 2013 Feb; 31(1):39-45. PubMed ID: 22669335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
    Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
    Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of PTEN is essential for maintenance of a malignant state in human gastric adenocarcinoma via upregulation of p‑AURKA mediated by activation of AURKA.
    Li L; Song Y; Liu Q; Liu X; Wang R; Kang C; Zhang Q
    Int J Mol Med; 2018 Jun; 41(6):3629-3641. PubMed ID: 29512701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma.
    Qi W; Cooke LS; Liu X; Rimsza L; Roe DJ; Manziolli A; Persky DO; Miller TP; Mahadevan D
    Biochem Pharmacol; 2011 Apr; 81(7):881-90. PubMed ID: 21291867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.
    Liu Y; Hawkins OE; Vilgelm AE; Pawlikowski JS; Ecsedy JA; Sosman JA; Kelley MC; Richmond A
    Clin Cancer Res; 2015 Dec; 21(23):5338-48. PubMed ID: 26152738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.
    Boi D; Souvalidou F; Capelli D; Polverino F; Marini G; Montanari R; Pochetti G; Tramonti A; Contestabile R; Trisciuoglio D; Carpinelli P; Ascanelli C; Lindon C; De Leo A; Saviano M; Di Santo R; Costi R; Guarguaglini G; Paiardini A
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
    Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
    Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma.
    Rishfi M; Krols S; Martens F; Bekaert SL; Sanders E; Eggermont A; De Vloed F; Goulding JR; Risseeuw M; Molenaar J; De Wilde B; Van Calenbergh S; Durinck K
    Eur J Med Chem; 2023 Feb; 247():115033. PubMed ID: 36549117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma.
    Zhang K; Wang T; Zhou H; Feng B; Chen Y; Zhi Y; Wang R
    Mol Ther Nucleic Acids; 2018 Dec; 13():176-188. PubMed ID: 30292139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.